Literature DB >> 1977644

Carcinoma of the cervix in the African setting.

K O Rogo1, J Omany, J N Onyango, S B Ojwang, U Stendahl.   

Abstract

Carcinoma of the cervix is the commonest female malignancy in sub-Saharan Africa today. A brief description of its prevalence and distribution is given. Kenyan data is then used to illustrate the predominance of advanced disease in mostly premenopausal women (70%) of high parity. Follow up is characteristically poor and treatment results, although difficult to calculate with accuracy, are also poor. These are compared to FIGO statistics. Against this background aspects peculiar to the tumor, patient and treatment facilities in Africa are cited and discussed with reference to current relevant literature.

Entities:  

Mesh:

Year:  1990        PMID: 1977644     DOI: 10.1016/0020-7292(90)90010-i

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  5 in total

1.  Predictors of cervical cancer being at an advanced stage at diagnosis in Sudan.

Authors:  Ahmed Ibrahim; Vibeke Rasch; Eero Pukkala; Arja R Aro
Journal:  Int J Womens Health       Date:  2011-11-11

2.  A strategic assessment of cervical cancer prevention and treatment services in 3 districts of Uttar Pradesh, India.

Authors:  Rasha Dabash; Jyoti Vajpayee; Martha Jacob; Ilana Dzuba; Nisha Lal; Jan Bradley; L B Prasad
Journal:  Reprod Health       Date:  2005-12-08       Impact factor: 3.223

3.  Local risk factors in genital human papilloma virus infection in cervical smears.

Authors:  Ec Ojiyi; Ie Dike; C Okeudo; C Ejikem; Ac Nzewuihe; A Agbata
Journal:  Ann Med Health Sci Res       Date:  2013-10

4.  Self-reported use of internet by cervical cancer clients in two National Referral Hospitals in Kenya.

Authors:  Lucy W Kivuti-Bitok; Geoff McDonnell; Ganesh P Pokhariyal; Abdul V Roudsari
Journal:  BMC Res Notes       Date:  2012-10-09

5.  Survival of cervix cancer patients in Kampala, Uganda: 1995-1997.

Authors:  H Wabinga; A V Ramanakumar; C Banura; A Luwaga; S Nambooze; D M Parkin
Journal:  Br J Cancer       Date:  2003-07-07       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.